These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 30069853)

  • 21. Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development.
    Karagiannis P; Takahashi K; Saito M; Yoshida Y; Okita K; Watanabe A; Inoue H; Yamashita JK; Todani M; Nakagawa M; Osawa M; Yashiro Y; Yamanaka S; Osafune K
    Physiol Rev; 2019 Jan; 99(1):79-114. PubMed ID: 30328784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating pediatric disorders with induced pluripotent stem cells.
    Durbin MD; Cadar AG; Chun YW; Hong CC
    Pediatr Res; 2018 Oct; 84(4):499-508. PubMed ID: 30065271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum starvation-induced cell cycle synchronization stimulated mouse rDNA transcription reactivation during somatic cell reprogramming into iPSCs.
    Zhao Q; Wu Y; Shan Z; Bai G; Wang Z; Hu J; Liu L; Li T; Shen J; Lei L
    Stem Cell Res Ther; 2016 Aug; 7(1):112. PubMed ID: 27515169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does transcription factor induced pluripotency accurately mimic embryo derived pluripotency?
    Lowry WE
    Curr Opin Genet Dev; 2012 Oct; 22(5):429-34. PubMed ID: 23079387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
    Menon S; Shailendra S; Renda A; Longaker M; Quarto N
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Differentiation of pluripotent stem cells into male germ cells: An update].
    Wang SY; Cui YG; Qin LJ
    Zhonghua Nan Ke Xue; 2017 May; 23(5):468-472. PubMed ID: 29717842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of germ cells in vitro in the era of induced pluripotent stem cells.
    Imamura M; Hikabe O; Lin ZY; Okano H
    Mol Reprod Dev; 2014 Jan; 81(1):2-19. PubMed ID: 23996404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Induced pluripotent stem cell technology and its application in disease research].
    Cai CY; Meng FL; Rao L; Liu YY; Zhao XL
    Yi Chuan; 2020 Nov; 42(11):1042-1061. PubMed ID: 33229312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome damage in induced pluripotent stem cells: assessing the mechanisms and their consequences.
    Hussein SM; Elbaz J; Nagy AA
    Bioessays; 2013 Mar; 35(3):152-62. PubMed ID: 23172728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
    Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
    Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using Microfluidics to Generate Human Naïve and Primed Pluripotent Stem Cells.
    Zorzan I; Gagliano O; Elvassore N; Martello G
    Methods Mol Biol; 2022; 2416():53-71. PubMed ID: 34870830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters.
    Chen H; Zuo Q; Wang Y; Song J; Yang H; Zhang Y; Li B
    BMC Biotechnol; 2017 Feb; 17(1):11. PubMed ID: 28193206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation and genetic modification of induced pluripotent stem cells.
    Schambach A; Cantz T; Baum C; Cathomen T
    Expert Opin Biol Ther; 2010 Jul; 10(7):1089-103. PubMed ID: 20528610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naïve Induced Pluripotent Stem Cells Generated From β-Thalassemia Fibroblasts Allow Efficient Gene Correction With CRISPR/Cas9.
    Yang Y; Zhang X; Yi L; Hou Z; Chen J; Kou X; Zhao Y; Wang H; Sun XF; Jiang C; Wang Y; Gao S
    Stem Cells Transl Med; 2016 Jan; 5(1):8-19. PubMed ID: 26676643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of blood T cells: Reprogramming human induced pluripotent stem cells into neuronal cells.
    Tsai PH; Chang YC; Lee YY; Ko YL; Yang YH; Lin CF; Chang YL; Yu WC; Shih YH; Chen MT
    J Chin Med Assoc; 2015 Jun; 78(6):353-9. PubMed ID: 26022695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial resetting and metabolic reprogramming in induced pluripotent stem cells and mitochondrial disease modeling.
    Hsu YC; Chen CT; Wei YH
    Biochim Biophys Acta; 2016 Apr; 1860(4):686-93. PubMed ID: 26779594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generating autologous hematopoietic cells from human-induced pluripotent stem cells through ectopic expression of transcription factors.
    Hwang Y; Broxmeyer HE; Lee MR
    Curr Opin Hematol; 2017 Jul; 24(4):283-288. PubMed ID: 28383341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.
    Araki R; Uda M; Hoki Y; Sunayama M; Nakamura M; Ando S; Sugiura M; Ideno H; Shimada A; Nifuji A; Abe M
    Nature; 2013 Feb; 494(7435):100-4. PubMed ID: 23302801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling blood diseases with human induced pluripotent stem cells.
    Georgomanoli M; Papapetrou EP
    Dis Model Mech; 2019 Jun; 12(6):. PubMed ID: 31171568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.